Skip to main content
Equibles

PROFUND ADVISORS LLC

Position in DHR — Danaher Corp /De/

CIK 1129919 BETHESDA, MD
Back to DHR Full portfolio

Position in DHR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,336,217
+$2,950 QoQ
Shares Held
7,015
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,002
of 2,109 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $15,038,497 across 17 Diagnostics & Research names. DHR ranks #6 (8.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IDXX
Idexx Laboratories Inc /De
 6,365 $3,350,790
2 TMO
Thermo Fisher Scientific Inc.
 4,138 $2,074,627
3 NTRA
Natera, Inc.
 6,205 $1,684,347
4 VCYT
Veracyte, Inc.
 24,694 $1,450,278
5 GRAL
GRAIL, Inc.
 20,078 $1,370,725
6 DHR
Danaher Corp /De/
This page 		7,015 $1,336,217
7 ILMN
Illumina, Inc.
 3,154 $554,567
8 CDNA
CareDx, Inc.
 16,518 $470,763

All Filings in DHR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,336,217 7,015
2026-03-31 $1,333,267 7,032
2025-12-31 $2,341,164 10,227
2025-09-30 $1,631,481 8,229
2025-06-30 $1,606,592 8,133
2025-03-31 $1,794,775 8,755
2024-12-31 $2,076,968 9,048
2024-09-30 $2,960,356 10,648
2024-06-30 $2,503,497 10,020
2024-03-31 $2,511,933 10,059
2023-12-31 $2,602,112 11,248
2023-09-30 $2,525,906 10,181
2023-06-30 $2,540,160 10,584
2023-03-31 $2,569,547 10,195
2022-12-31 $20,382,927 76,795
2022-09-30 $19,435,289 75,246
2022-06-30 $19,678,731 77,622
2022-03-31 $24,731,823 84,314
2021-12-31 $30,607,138 93,028
2021-09-30 $4,007,647 13,164
2021-06-30 $3,462,380 12,902
2021-03-31 $2,869,769 12,750
2020-12-31 $3,156,831 14,211
2020-09-30 $3,091,708 14,358
2020-06-30 $3,169,854 17,926
2020-03-31 $1,940,231 14,018